Sparrow Pharmaceuticals Funding & Investors
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
sparrowpharma.comTotal Amount Raised: $61,275,256
Sparrow Pharmaceuticals Funding Rounds
Series Unknown
$10,200,000
Series Unknown Investors
OrbiMed AdvisorsU.S. Venture Partners (USVP)RiverVestSeries A
$50,000,000
Series A Investors
OrbiMed AdvisorsU.S. Venture Partners (USVP)RiverVestSeries Unknown
$1,075,255
Funding info provided by Diffbot.